Search

everythinglearnresearchcommunity

for

Search:↓

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Finasteride treats hair loss and reduces prostate cancer risk.

Avoiding certain nutrients and drugs may help manage pemphigus.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Ozone therapy might improve cancer treatment and reduce its side effects.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.